Palisade Asset Management Decreased Abbott Laboratories (ABT) Position By $316,730; Biglari Capital Cut Its Investors Title Co (ITIC) Position

June 19, 2017 - By Adrian Mccoy

Biglari Capital Corp decreased Investors Title Co (ITIC) stake by 7.13% reported in 2016Q4 SEC filing. Biglari Capital Corp sold 4,313 shares as Investors Title Co (ITIC)’s stock rose 40.02%. The Biglari Capital Corp holds 56,196 shares with $8.89 million value, down from 60,509 last quarter. Investors Title Co now has $357.32 million valuation. The stock declined 0.10% or $0.2 reaching $193.7 per share. About shares traded. Investors Title Company (NASDAQ:ITIC) has risen 101.17% since June 19, 2016 and is uptrending. It has outperformed by 84.47% the S&P500.

Palisade Asset Management Llc decreased Abbott Laboratories (ABT) stake by 3.4% reported in 2016Q4 SEC filing. Palisade Asset Management Llc sold 8,335 shares as Abbott Laboratories (ABT)’s stock declined 3.42%. The Palisade Asset Management Llc holds 236,731 shares with $9.09M value, down from 245,066 last quarter. Abbott Laboratories now has $83.90B valuation. The stock rose 0.10% or $0.05 reaching $48.26. About 25 shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since June 19, 2016 and is uptrending. It has underperformed by 0.80% the S&P500.

Since December 20, 2016, it had 1 buy, and 19 sales for $8.43 million activity. On Tuesday, February 28 Contreras Jaime sold $592,157 worth of Abbott Laboratories (NYSE:ABT) or 13,155 shares. Shares for $38,569 were sold by ALLEN HUBERT L. Warmuth Michael J sold 3,851 shares worth $174,797. 2,066 Abbott Laboratories (NYSE:ABT) shares with value of $93,776 were sold by Salvadori Daniel Gesua Sive. 555 shares were sold by Watkin Jared, worth $24,965. Another trade for 1,912 shares valued at $86,068 was made by Mason Heather L on Tuesday, February 28. Funck Robert E sold $1.16M worth of stock.

Among 17 analysts covering Abbott Laboratories (NYSE:ABT), 9 have Buy rating, 0 Sell and 8 Hold. Therefore 53% are positive. Abbott Laboratories had 51 analyst reports since July 24, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Outperform” rating in Thursday, July 23 report. RBC Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Thursday, January 26 with “Outperform” rating. The firm earned “Outperform” rating on Wednesday, March 1 by RBC Capital Markets. Barclays Capital upgraded the shares of ABT in report on Wednesday, October 7 to “Overweight” rating. The firm earned “Buy” rating on Friday, June 16 by Jefferies. The company was upgraded on Monday, December 7 by Jefferies. The rating was maintained by Jefferies with “Buy” on Tuesday, June 14. As per Monday, January 4, the company rating was downgraded by Morgan Stanley. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, July 23 report. The stock of Abbott Laboratories (NYSE:ABT) earned “Outperform” rating by RBC Capital Markets on Friday, January 29.

Investors sentiment increased to 1.01 in Q4 2016. Its up 0.05, from 0.96 in 2016Q3. It improved, as 83 investors sold ABT shares while 496 reduced holdings. 103 funds opened positions while 481 raised stakes. 1.06 billion shares or 1.63% more from 1.04 billion shares in 2016Q3 were reported. Cypress Asset Inc Tx accumulated 18,353 shares. Cwm Ltd Limited Liability Company holds 180,605 shares. Cullen Cap Management Llc, a New York-based fund reported 11,880 shares. Aviva Pcl reported 0.22% of its portfolio in Abbott Laboratories (NYSE:ABT). Haverford Tru reported 0.07% in Abbott Laboratories (NYSE:ABT). Zeke Limited Liability Corporation owns 0.21% invested in Abbott Laboratories (NYSE:ABT) for 20,472 shares. Smith Moore & has 0.43% invested in Abbott Laboratories (NYSE:ABT). Schulhoff Company holds 22,680 shares or 0.54% of its portfolio. Pentwater Mgmt Limited Partnership invested in 1,176 shares. 1.23M are held by Keybank Natl Association Oh. Palisades Hudson Asset Mngmt Limited Partnership invested in 6,144 shares or 0.14% of the stock. Bedrijfstakpensioenfonds Voor De Media Pno, Netherlands-based fund reported 23,500 shares. Moreover, Blb&B Limited Liability Corporation has 0.47% invested in Abbott Laboratories (NYSE:ABT) for 70,423 shares. Broderick Brian C holds 1.83% or 110,015 shares. Kornitzer Capital Mgmt Ks holds 670,831 shares or 0.48% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: